BRCA2 and prostate cancer: While the loss of BRCA2 function and its consequences in prostate cancer is being reconsidered [50], [51], [52], [53], BRCA2 is generally regarded as a “tumor suppressor”, with an established role in maintaining genomic stability via its function in the homologous recombination pathway for double-strand DNA repair.